NCT03236233View on ClinicalTrials.gov

A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

December 15, 2017

Study Completion Date

December 15, 2017

Conditions
Respiratory Syncytial Virus (RSV)
Interventions
DRUG

PC786 - Single doses

Safety and tolerability of single doses

DRUG

Placebo - Single doses

Safety and tolerability of single doses

DRUG

PC786 - Repeat doses

Safety and tolerability of repeat doses

DRUG

Placebo - Repeat doses

Safety and tolerability of repeat doses

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research, London

All Listed Sponsors
lead

Pulmocide Ltd

INDUSTRY

NCT03236233 - A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786 | Biotech Hunter | Biotech Hunter